Mean percent survival of adult winter bees (n = 180/group) over time (in days) after inoculation with 1 × 10⁶ CFU/bee <i>M. plutonius</i> ATCC3511 or 2019BC1 in laborato... by Midhun Sebastian Jose (19336846)

Mean percent survival of adult summer worker bees (n = 180/group) over time (in days) after inoculation with incremental doses of (CFU/bee) of <i>M. plutonius</i> in laboratory cag... by Midhun Sebastian Jose (19336846)

Mean (±SD) syrup consumption (µL/bee) of adult winter worker bees (n = 180/group) over time (in days) after inoculation with either <i>M. plutonius</i> ATCC 3511 or <i>M. plutonius... by Midhun Sebastian Jose (19336846)

Mean (±SD) sugar consumption (µL/bee) of newly emerged summer worker bees in laboratory inoculated with 1 × 10⁷ CFU/bee <i>M. plutonius</i> 2019BC1 and or treated with o... by Midhun Sebastian Jose (19336846)

Influence of anti-<i>Leishmania</i> compounds added to the sugar diet on the infection of <i>Lu. longipalpis</i> with <i>Le. amazonensis.</i> by Tainá Neves Ferreira (21601579)

Median ± IQR <i>M. plutonius</i> bacterial load (CFU/bee) of adult winter worker bees in the laboratory inoculated with A. <i>M. plutonius</i> ATCC3511 or B. <i>M. plutonius</i> 20... by Midhun Sebastian Jose (19336846)

Mean (±SD) sugar consumption (µL/bee) of adult summer worker bees (n = 180/group) over time (in days) after inoculation with A. one of 6 incremental doses of of <i>M. plutonius</i>... by Midhun Sebastian Jose (19336846)

Median ± IQR <i>M. plutonius</i> bacterial load (CFU/bee) of adult summer worker bees over time after introduction on D3 into field colonies. by Midhun Sebastian Jose (19336846)

Median ± IQR <i>M. plutonius</i> bacterial load (CFU/bee) of caged adult summer worker bees over time after inoculation with A. low (1 × 10⁴ CFU/bee)B. Medium (1 × 10<su... by Midhun Sebastian Jose (19336846)

Median ± IQR <i>M. plutonius</i> bacterial load (CFU/bee) of caged adult summer worker bees (n = 114 bees/group) introduced on day 3 into field colonies later treated 3 times at 4... by Midhun Sebastian Jose (19336846)

The flow-diagram for the randomised clinical study. by Iva Milinkovic (22331710)

Subjects:

Total bacterial count values at baseline and six months after treatment using systemic and local antibiotic treatment. by Iva Milinkovic (22331710)

Subjects:

Mean Values and Standard Deviations (Mean [±SD]) of Clinical Parameters: periodontal probing depth (PPD), clinical attachment level (CAL), bleeding on probing (BOP), and plaque ind... by Iva Milinkovic (22331710)

Subjects:

Difference in (a) IL-17, and (b) TNF-α relative gene expression levels between baseline and six months after treatment using systemic and local antibiotic treatment. by Iva Milinkovic (22331710)

Subjects:

Raw database. by Franco Romaní-Romaní (21989788)

“…No consistent upward trend in PT scores was observed over the study period; scores decreased by 0.088 points per additional year (CI95% CI: −0.147 to −0.029, p = 0.003). …”

CONSORT diagram. by Bon-Wook Koo (13773694)

“…The overall proportion of patients who experienced any adverse events was 57.8% in the GDFT group and 70.1% in the conventional group (P = 0.038), of which the occurrence of pleural effusion was significantly lower in the GDFT group than in the conventional group (9.5% vs. 19.7%; P = 0.024). …”

Raw data. by Bon-Wook Koo (13773694)

“…The overall proportion of patients who experienced any adverse events was 57.8% in the GDFT group and 70.1% in the conventional group (P = 0.038), of which the occurrence of pleural effusion was significantly lower in the GDFT group than in the conventional group (9.5% vs. 19.7%; P = 0.024). …”

Postoperative outcomes. by Bon-Wook Koo (13773694)

“…The overall proportion of patients who experienced any adverse events was 57.8% in the GDFT group and 70.1% in the conventional group (P = 0.038), of which the occurrence of pleural effusion was significantly lower in the GDFT group than in the conventional group (9.5% vs. 19.7%; P = 0.024). …”

Postoperative complications. by Bon-Wook Koo (13773694)

“…The overall proportion of patients who experienced any adverse events was 57.8% in the GDFT group and 70.1% in the conventional group (P = 0.038), of which the occurrence of pleural effusion was significantly lower in the GDFT group than in the conventional group (9.5% vs. 19.7%; P = 0.024). …”

Quantification of bacterial adhesion revealed a significant decrease in the adhesion of <i>S. aureus</i>, <i>S. epidermidis</i>, and <i>P. aeruginosa</i> on blotted corneas of mice treated with 0.5% bupivacaine (BUP) combined with topical (TOP) application, following subconjunctival injection (SCI) of CGRP, 24 hours before the final BUP treatment (day 14) and again one hour prior to the final bupivacaine injection on day 15. by Ananya Datta (19932144)